FOLH1 and prostate cancer: It has been found that GRPR expression more clearly correlates to Gleason scoring than prostate specific membrane antigen (PSMA), with higher expression evident in early-stage prostate cancer and, most importantly, minimal expression in prostate hyperplasia (Faviana et al. 2021).